ArticleSurgical endoscopy2026
Surgical repair of paraesophageal hernia resolves unexplained iron deficiency anemia in the vast majority of patients: a propensity-matched multicenter study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParaesophageal hernias (PEH) frequently associate with iron deficiency anemia (IDA) through unclear mechanisms. We investigated whether surgical repair effectively treats unexplained IDA in patients with PEH.
methodsThis multicenter retrospective study (2010-2024) analyzed 1700 patients undergoing hiatal hernia repair across Asuta Medical Centers. After excluding patients with identifiable bleeding sources (Cameron lesions, erosive gastritis, ulcers), 522 patients remained: 136 with unexplained IDA and 386 controls. Propensity score matching (1:3) aligned 99 anemic patients with 297 controls based on age, sex, BMI, and comorbidities. Primary endpoint was anemia resolution at 12 months (hemoglobin > 12 g/dL females, > 13 g/dL males without iron supplementation).
resultsBaseline hemoglobin was 10.5 ± 1.4 vs 13.9 ± 1.2 g/dL (p < 0.001). Anemia severity was mild (62.6%), moderate (31.3%), or severe (6.1%). Despite profound anemia, 42.4% were completely asymptomatic at presentation. Prior iron therapy had failed in 78.2% over 5.8 ± 3.2 months. Anemia resolution occurred in 93.4% (92/99) at 12 months, with 88.9% achieving normal hemoglobin by 3 months. Mean hemoglobin increased by 3.2 g/dL (95% CI 2.9-3.5, p < 0.001), with ferritin normalizing from 19.3 ± 11.8 to 95.3 ± 38.5 ng/mL. Iron supplementation was successfully discontinued in 82.8% of patients. Among 16 patients with hernia recurrence, 75% maintained normal hemoglobin despite anatomical failure. Control group hemoglobin remained unchanged (13.9 ± 1.2 to 13.9 ± 1.1 g/dL, p = 0.892). Due to only 7 non-resolution events, multivariate analysis was not performed; however, diabetes (71.4% vs. 28.3%) and chronic kidney disease (28.6% vs. 3.3%) were associated with persistent anemia.
conclusionsUnexplained IDA resolves in > 90% of patients following PEH repair, with durable results often maintained despite anatomical recurrence. These findings suggest PEH repair should be considered for patients with unexplained, refractory IDA. Prospective studies are needed to establish evidence-based criteria for this underrecognized indication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.